Intracorporeal LVAD implantation in pediatric patients: A single-center 10 years' experience

BACKGROUNDMechanical cardiac support is currently an effective strategy to reduce morbidity and mortality in pediatric patients. However, solid evidence regarding the feasibility of intracorporeal devices in children still needs to be provided. We report our 10-year experience with intracorporeal le...

Full description

Saved in:
Bibliographic Details
Published in:Artificial organs 2024, Vol.48 (4), p.408-417
Main Authors: Cao, Irene, Italiano, Enrico G, Bertelli, Francesco, Motta, Raffaella, Castaldi, Biagio, Pergola, Valeria, Guariento, Alvise, Scattolin, Fabio, Di Salvo, Giovanni, Vida, Vladimiro, Padalino, Massimo A
Format: Report
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:BACKGROUNDMechanical cardiac support is currently an effective strategy to reduce morbidity and mortality in pediatric patients. However, solid evidence regarding the feasibility of intracorporeal devices in children still needs to be provided. We report our 10-year experience with intracorporeal left ventricular assist devices (LVAD) in children.MATERIALS AND METHODSWe included all patients undergoing intracorporeal, continuous-flow LVAD implantation between 2012 and 2022. Baseline and postoperative data were collected from the institutional database.RESULTSSeven HeartWare and 4 HeartMate3 were implanted in 11 patients (median age 13.9 years, median body surface area - BSA - 1.42 m2, IQR 1.06-1.68). The most frequent indication to LVAD implant was dilated cardiomyopathy (72.7%). All candidates underwent a thorough preoperative advanced imaging. Three-dimensional reconstructions and implant fit simulation were performed when BSA was
ISSN:1525-1594
DOI:10.1111/aor.14716